Oncology Pharma Inc.
ONPH
$0.0001
$0.000.00%
OTC PK
| 12/31/2004 | 09/30/2004 | 06/30/2004 | 03/31/2004 | 12/31/2003 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 94.00K | 139.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 94.00K | 139.00K |
| Cost of Revenue | -- | -- | -- | 29.00K | 154.00K |
| Gross Profit | -- | -- | -- | 65.00K | -15.00K |
| SG&A Expenses | 81.00K | 15.00K | 118.00K | 363.00K | 410.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.00K | 15.00K | 118.00K | 465.00K | 667.00K |
| Operating Income | -81.00K | -15.00K | -118.00K | -371.00K | -528.00K |
| Income Before Tax | -81.00K | -15.00K | -178.00K | -233.00K | -528.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -81.00K | -15.00K | -178.00K | -233.00K | -528.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -81.00K | -15.00K | -178.00K | -233.00K | -528.00K |
| EBIT | -81.00K | -15.00K | -118.00K | -371.00K | -528.00K |
| EBITDA | -60.80K | 5.30K | -97.80K | -359.00K | -507.00K |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |